Treatment of Asthma with an Anti-interleukin-5 Antibody

被引：0
|
作者：
Kroegel, C. [1 ]
机构：
[1] Friedrich Schiller Univ, Abt Pneumol & Allergol Immunol, Med Klin 1, Erlanger Allee 101, D-07740 Jena, Germany
来源：
PNEUMOLOGE | 2009年 / 6卷 / 05期
关键词：
D O I：
10.1007/s10405-009-0320-6
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：328 / 329
页数：2
相关论文
共 50 条
  • [41] Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions
    Büttner, C
    Lun, A
    Splettstoesser, T
    Kunkel, G
    Renz, H
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (05) : 799 - 803
  • [42] Effects of mepolizumab, an anti-interleukin-5 monoclonal antibody, on blood eosinaphil counts in patients with hypereosinophilic syndrome
    Weller, P. E.
    Gleich, G. J.
    Busse, W. W.
    Rothenberg, M. E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S209 - S209
  • [43] Corticosteroid-sparing effects of Mepolizumab, an anti-interleukin-5 monoclonal antibody, in patients with hypereosinophilic syndrome
    Rosenwasser, L. J.
    Schwartz, L. B.
    Sheikh, J.
    Klion, A. D.
    Rothenberg, M. E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S160 - S160
  • [44] Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial
    Straumann, A.
    Conus, S.
    Grzonka, P.
    Kita, H.
    Kephart, G.
    Bussmann, C.
    Beglinger, C.
    Smith, D. A.
    Patel, J.
    Byrne, M.
    Simon, H-U
    [J]. GUT, 2010, 59 (01) : 21 - 30
  • [45] Efficacy and safety of anti-interleukin-5 therapy in patients with asthma: A pairwise and Bayesian network meta-analysis
    He, Lu-Lu
    Zhang, Lei
    Jiang, Lei
    Xu, Feng
    Fei, Dong-Sheng
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 64 : 223 - 231
  • [46] LEBRIKIZUMAB Anti-interleukin-13 monoclonal antibody, Treatment of asthma
    Pelaia, G.
    Vatrella, A.
    Gallelli, L.
    Busceti, M. T.
    Terracciano, R.
    Maselli, R.
    [J]. DRUGS OF THE FUTURE, 2014, 39 (02) : 105 - 111
  • [47] Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion
    Tello, Khodr
    Hoffmann, Andreas
    Beutel, Bjoern
    Greulich, Timm
    Vogelmeier, Claus Franz
    Richter, Manuel Jonas
    Kuhnert, Stefan
    Boeselt, Tobias
    Alter, Peter
    Holland, Angelique
    Idzko, Marco
    Buhl, Roland
    Koczulla, Andreas Rembert
    [J]. RESPIRATORY MEDICINE CASE REPORTS, 2019, 28
  • [48] Anti-interleukin 5 strategies as a potential treatment for asthma
    Singh, AD
    Sanderson, CJ
    [J]. THORAX, 1997, 52 (05) : 483 - 485
  • [49] Anti-interleukin-5 and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5 levels
    Ishigami, Tomoaki
    Abe, Kaito
    Aoki, Ichiro
    Minegishi, Shintaro
    Ryo, Akihide
    Matsunaga, Satoko
    Matsuoka, Kazuhiro
    Takeda, Hiroyuki
    Sawasaki, Tatsuya
    Umemura, Satoshi
    Endo, Yaeta
    [J]. FASEB JOURNAL, 2013, 27 (09): : 3437 - 3445
  • [50] Anti-Interleukin-5 Therapy in Patients with Asthma and Chronic Obstructive Pulmonary Disease Overlap: A Single-Center Review
    Saint-Pierre, M. D.
    Mavromatis, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
12345